Wednesday, December 9, 2009

Ovarian Cancer Diagnostics

As reported today in numerous sources, Arrayit Diagnostics licensed ovarian cancer biomarkers from Wayne State University. Our test will aim to effectively screen for early-stage ovarian cancer in women who are not yet symptomatic, addressing the fact that the disease often presents with largely non-specific symptoms during its initial stages, and is diagnosed only when later-stage symptoms manifest and the disease has metastasized to other parts of the body. For more information see www.arrayit.com